WaveMan · Form 4
Bonita David P insider trades
> Search tickers & screens ⌘K
LIVE

Bonita David P insider trades

Bonita David P has filed 40 Form 4s with the SEC that we hold, for ImageneBio, Inc. (IMA) (Director), RPTX (Director), Prelude Therapeutics Inc (PRLD) (Director, 10% owner) and THRD (Director), among 7 companies in all. Across all of them we count 12 purchases worth $51.2M and 33 sales worth $6.4M reported on Form 4. In the last 12 months: 2 purchases ($12.5M) and 0 sales ($0). The largest single trade was a purchase of 1,666,666 shares of Enliven Therapeutics, Inc. worth $10.0M, dated 2021-07-16. The first filing on our record is dated 2021-07-21 and the latest 2026-06-18.

ImageneBio, Inc. (IMA)

Director · 10 filings · 5 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-06-22P, purchase reported on Form 466,806$237.2K2022-06-24
2022-06-23P, purchase reported on Form 423,419$86.9K2022-06-24
2022-06-24P, purchase reported on Form 465,965$288.3K2022-06-24
2022-06-24P, purchase reported on Form 496,035$515.7K2022-06-24
2025-07-25P, purchase reported on Form 483,611$2.5M2025-07-30

RPTX

Director · 9 filings · 30 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-08-17S, sale reported on Form 416,886$576.2K2021-08-25
2021-08-17S, sale reported on Form 4512$17.5K2021-08-25
2021-08-17S, sale reported on Form 416,886$576.2K2021-08-19
2021-08-17S, sale reported on Form 4512$17.5K2021-08-19
2021-08-18S, sale reported on Form 42,852$96.9K2021-08-25
2021-08-18S, sale reported on Form 478$2.7K2021-08-25
2021-08-18S, sale reported on Form 478$2.7K2021-08-19
2021-08-18S, sale reported on Form 42,852$96.9K2021-08-19
2021-08-23S, sale reported on Form 46,885$234.5K2021-08-25
2021-08-23S, sale reported on Form 4209$7.1K2021-08-25
2021-08-24S, sale reported on Form 43,920$133.6K2021-08-25
2021-08-24S, sale reported on Form 4119$4.1K2021-08-25
2021-08-25S, sale reported on Form 46,874$236.1K2021-08-25
2021-08-25S, sale reported on Form 4208$7.1K2021-08-25
2021-08-26S, sale reported on Form 4126$4.3K2021-08-30
2021-08-26S, sale reported on Form 44,157$143.5K2021-08-30
2021-08-27S, sale reported on Form 4209$7.1K2021-08-30
2021-08-27S, sale reported on Form 46,884$233.6K2021-08-30
2021-08-30S, sale reported on Form 46,500$220.5K2021-08-30
2021-08-30S, sale reported on Form 4197$6.7K2021-08-30
2021-08-31S, sale reported on Form 48,223$279.1K2021-09-02
2021-08-31S, sale reported on Form 4249$8.5K2021-09-02
2021-09-01S, sale reported on Form 412,586$427.7K2021-09-02
2021-09-01S, sale reported on Form 4382$13.0K2021-09-02
2021-09-02S, sale reported on Form 4483$16.5K2021-09-02
2021-09-02S, sale reported on Form 415,941$545.8K2021-09-02
2021-09-03S, sale reported on Form 4212$7.2K2021-09-08
2021-09-03S, sale reported on Form 46,985$237.5K2021-09-08
2021-09-07S, sale reported on Form 426$8822021-09-08
2021-09-07S, sale reported on Form 4861$29.2K2021-09-08

Prelude Therapeutics Inc (PRLD)

Director, 10% owner · 7 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-05-22P, purchase reported on Form 4869,565$5.0M2023-05-24
2026-04-21P, purchase reported on Form 41,689,189$7.5M2026-04-23
2026-04-21P, purchase reported on Form 41,126,126$5.0M2026-04-23

THRD

Director · 6 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2022-09-19P, purchase reported on Form 4300,000$5.1M2022-09-21

AFIB

Director · 3 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-07-19P, purchase reported on Form 4714,285$10.0M2021-07-21
2021-07-19P, purchase reported on Form 4357,143$5.0M2021-07-21

TCDA

Director, 10% owner · 3 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-11-22S, sale reported on Form 41,034,421$227.6K2022-11-25
2022-11-23S, sale reported on Form 45,617,300$1.2M2022-11-25
2022-11-25S, sale reported on Form 43,629,226$798.4K2022-11-25

Enliven Therapeutics, Inc. (IMRA)

Director, 10% owner · 2 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2021-07-16P, purchase reported on Form 41,666,666$10.0M2021-07-23
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1572451) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms